These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1375536)

  • 1. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
    Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.
    Remacle-Bonnet M; Garrouste F; el Atiq F; Marvaldi J; Pommier G
    J Clin Invest; 1995 Jul; 96(1):192-200. PubMed ID: 7542277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells.
    Remacle-Bonnet M; Garrouste F; el Atiq F; Roccabianca M; Marvaldi J; Pommier G
    Int J Cancer; 1992 Dec; 52(6):910-7. PubMed ID: 1281142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
    J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
    Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A).
    Giannini S; Maggi M; Cresci B; Finetti G; Bonaccorsi L; Luconi M; Rotella CM; Forti G; Serio M; Baldi E
    Gynecol Oncol; 1996 Jun; 61(3):333-40. PubMed ID: 8641611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
    Baghdiguian S; Verrier B; Marvaldi J; Fantini J
    J Cell Physiol; 1992 Jan; 150(1):168-74. PubMed ID: 1730780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6].
    Baghdiguian S; Pichon J; Marvaldi J; Fantini J
    Bull Cancer; 1991; 78(9):807-17. PubMed ID: 1751832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
    Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
    Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
    Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
    J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein.
    Culouscou JM; Shoyab M
    Cancer Res; 1991 Jun; 51(11):2813-9. PubMed ID: 1709585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line.
    Culouscou JM; Remacle-Bonnet M; Garrouste F; Fantini J; Marvaldi J; Pommier G
    J Cell Physiol; 1990 Jun; 143(3):405-15. PubMed ID: 1694180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
    Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
    J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.
    Fantini J; Rognoni JB; Culouscou JM; Pommier G; Marvaldi J; Tirard A
    J Cell Physiol; 1989 Oct; 141(1):126-34. PubMed ID: 2674159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
    Baghdiguian S; Verrier B; Gerard C; Fantini J
    Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells.
    Sullivan KA; Kim B; Buzdon M; Feldman EL
    Brain Res; 1997 Jan; 744(2):199-206. PubMed ID: 9027379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.
    Fleck JF; Sledge GW; Benenati SV; Frolik CA; Roth BJ; Hirsch KS
    Cancer Res; 1991 Aug; 51(16):4395-401. PubMed ID: 1678315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.